GlassScriptPhysician profile
Kurt M Heil
NPI 1316911951
$1,233.19
in general payments reported to CMS, 2019-2025
19 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.27 · 2020: $18.13 · 2021: $138 · 2022: $28.18 · 2023: $174 · 2024: $373 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $243.38 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $164.96 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $135.47 | 2022-2025 | |
| Abbott Laboratories | $133.94 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $117.35 | 2024-2025 | Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $66.84 | 2025 | Zoryve |
| Sanofi Pasteur INC. | $57.96 | 2019-2025 | |
| Exact Sciences Corporation | $50.42 | 2025 | The Cologuard Plus Collection Kit |
| Tosoh Bioscience, INC. | $47.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.52 | 2024-2025 | Jardiance, Tradjenta |
| Amgen INC. | $29.84 | 2024 | Evenity, Prolia |
| E.R. Squibb & Sons, L.L.C. | $22.04 | 2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $19.78 | 2025 | |
| Glaxosmithkline, LLC. | $18.83 | 2023 | Bexsero, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $17.88 | 2024 | Spravato |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $17.70 | 2024 | Entre Plus, Flexitouch Plus |
| Philips North America LLC | $17.63 | 2025 | Extended Holter |
| Currax Pharmaceuticals LLC | $14.46 | 2023 | Contrave, Onzetra Xsail |
| Dexcom, INC. | $14.19 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Heil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.